Publications for Mitchell S. Cairo

NYMC School of Medicine
NYMC School of Health Sciences and Practice
  • Chu, Y., Yahr, A., Ayello, J., Van De Ven, C., Barth, M., Czuczman, M., & Cairo, M. S. (2014). Anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer (NK) cells significantly mediate rituximab sensitive and resistant Burkitt lymphoma (BL) regression and improve survival in human BL xenografted NSG mice. Biology of Blood and Marrow Transplantation, 20(2 Suppl), S257.

  • Geyer, M. B., Radhakrishnan, K., Van de Ven, C., Suri, M. S., Ayello, J., & Cairo, M. S. (2014). Enhanced survival during experimental Listeria monocytogenes sepsis in neonatal mice prophylactically treated with Th1 and macrophage immunoregulatory cytokines and mediators  The Pediatric Infectious Disease Journal, 33(12), e330-e337. doi:10.1097/INF.0000000000000442

  • Goldman, S., Smith, L., Galardy, P., Perkins, S. L., Frazer, J. K., Sanger, W., . . . Cairo, M. S. (2014). Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: A Children's Oncology Group report. British Journal of Haematology, 167(3), 394-401.  doi:10.1111/bjh.13040

  • Hitzler, J. K., He, W., Doyle, J., Cairo, M., Camitta, B. M., Chan, K. W., . . . CIBMTR Pediatric Cancer Working Committee. (2014). Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. Pediatric Blood & Cancer, 61(6), 1126-1128. doi:10.1002/pbc.24918

  • Hochberg, J. C., Cairo, M. S., & Friedman, D. M. (2014). Cardio-oncology issues among pediatric cancer and stem cell transplant survivors. Cardiology in Review, 22(6), 268-274.  doi:10.1097/CRD.0000000000000030

  • Hochberg, J. C., El-Mallawany, N. K., & Cairo, M. S. (2014). Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults. Clinical Lymphoma, Myeloma & Leukemia, 14(Suppl.), S6-S13. doi:10.1016/j.clml.2014.04.015

  • Huang, X., Greene, J., Chu, Y., Hamby, C.Cairo, M. S., . . . Zhou, X. (2014). Chimeric antigen receptor (CAR) T cell immunotherapy for poor risk sarcomas. Biology of Blood and Marrow Transplantation, 20(2 Suppl), S184-S185.

  • Lee, S., Yin, C., Ayello, J., Van De Ven, C., & Cairo, M. S. (2014). Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (CAS) system mediated endogenous CD19 gene knockout model in burkitt lymphoma. Cancer Research, 74(19 Suppl.), 3617.

  • Lee, S. , Yin, C., O'Connell, T., Ayello, J., Van De Ven, C., & Cairo, M. S. (2014). Transcription activator-like effector nucleases (TALENs) mediated silencing of Bruton's tyrosine kinase (BTK) inhibits phosphorylation of Erk in Burkitt lymphoma . Cancer Research, 74(19 Suppl.), 3112.  doi:10.1158/1538-7445.AM2014-3112

  • Liao, Y., Itoh, M., Yang, A., Zhu, H., Roberts, S., Highet, A. M., . . . Cairo, M. S. (2014). Human cord blood derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa. Cell Transplantion, 23(3), 303-317. doi:10.3727/096368913X663569

  • Liao, Y., Ivanova, L., Surapaneni, B., Yahr, A., & Cairo, M. S. (2014). Xenotransplantation of human cord blood derived unrestricted somatic stem cells rescue the blistering phenotype in a murine model of recessive dystrophic epidermolysis bullosa. Biology of Blood and Marrow Transplantation, 20(2 Suppl), S185-S186.

  • McClune, B. L., Ahn, K. W., Wang, H. L., Antin, J. H., Artz, A. S., Cahn, J. Y., . . . Cairo, M. S. (2014). Allotransplantation for patients age >/=40 years with non-Hodgkin lymphoma: Encouraging progression-free survival. Biology of Blood and Marrow Transplantation, 20(7), 960-968. doi:10.1016/j.bbmt.2014.03.013

  • McGuinn, C., Geyer, M. B., Jin, Z., Garvin, J. H., Satwani, P., Bradley, M. B., . . . Cairo, M. S. (2014). Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia. Pediatric Blood & Cancer, 61(7), 1289-1294. doi:10.1002/pbc.24976

  • Miles, R., Galardy, P., Giulino, L. G., Goldman, S., & Cairo, M. S. (2014). Childhood and adolescent B-cell lymphoma: Bench to bedside and back to bench. In R. Srivastava, W. Maksymowicz, & W. Lopaczynski (Eds.), Lost in Translation: Barriers to incentives for translational research in medical sciences (pp. 247-285). Singapore: World Scientific Publishing Company.

  • O'Connell, T., Yin, C., Barth, M., Miles, R., Ayello, J., Harrison, L., . . . Cairo, M. (2014). Ibrutinib significantly alters cell proliferation and apoptosis in BL and PMBL: Ibrutinib may be a potential adjuvant therapy in the treatment of BL and/or PMBL. Pediatric Blood and Cancer, 61(Suppl 2), S200-S201.

  • Qualter, E., Satwani, P., Ricci, A., Jin, Z., Geyer, M. B., Alobeid, B., . . . Cairo, M. S. (2014). A comparison of bronchoalveolar lavage versus lung biopsy in pediatric recipients after stem cell transplantation. Biology of Blood and Marrow Transplantation, 20(8), 1229-1237. doi:10.1016/j.bbmt.2014.04.019

  • Satwani, P., Bavishi, S., Saha, A., Zhao, F., Ayello, J., Chu, Y., . . . Cairo, M. S. (2014). Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity. Cytotherapy, 16(10), 1431–1440. doi:10.1016/j.jcyt.2014.03.008

  • Satwani, P., Jin, Z., Bhatia, M., Garvin, J., George, D., . . . Cairo, M. S. (2014). Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic stem cell transplantation in children, adolescents and young adults with poor risk refractory or recurrent Hodgkin (HL) and non-Hodgkin lymphoma (NHL). Biology of Blood and Marrow Transplantation, 20(2 Suppl.), S85.

  • Smock, K. J., Agarwal, A. M., Lim, M. S., Tripp, S. R., Miles, R. R., Patel, J. L., . . . Cairo, M. S. (2014). Expression of Notch1 and mTOR pathway proteins in pediatric lymphoblastic lymphoma; a Children's Oncology Group report. Journal of Hematopathology, 7(1), 9-14. doi:10.1007/s12308-014-0200-9

  • Talano, J. A., Abikoff, C. M., Dozor, A. J., Friedman, D. M., Shi, Q., . . . Cairo, M. S (2014). Familial haploidentical (FHI) T-cell depleted (TCD) with T-cell addback stem cell transplantation for patients with high-risk sickle cell disease (SCD) (IND 14359) Biology of Blood and Marrow Transplantation, 20(2 Suppl), S135-S136. doi:10.1016/j.bbmt.2013.12.208

  • Talano, J. A., & Cairo, M. S. (2014). Smoothing the crescent curve: Sickle cell disease. Hematology 2014, 2014(1), 468-474. doi:10.1182/asheducation-2014.1.468

  • Talano, J. M., Pulsipher, M. A., Symons, H. J., Militano, O., Shereck, E. B., Giller, R. H., . . . Cairo, M. S. (2014). New frontiers in pediatric Allo-SCT. Bone Marrow Transplantation, 49(9), 1139-1145. doi:10.1038/bmt.2014.89

  • Tiwari, A. A., Ayello, J., Van De Ven, C., Barth, M. J., & Cairo, M. S. (2014). Obinutuzumab (GA101) significantly increases overall survival against CD20+ rituximab-sensitive and-resistant Burkitt (BL) and acute lymphoblastic leukemia (B-ALL): Potential targeted therapy in patients with high risk BL and pre-B-ALL. Cancer Research, 74(19 Suppl.), 2902.

  • Warlick, E. D., Paulson, K., Brazauskas, R., Zhong, X., Miller, A. M., Camitta, B. M., . . . Cairo, M. S. (2014). Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. Biology of Blood and Marrow Transplantation, 20(2), 202-208. doi:10.1016/j.bbmt.2013.10.023

  • Wirk, B., Fenske, T. S., Hamadani, M., Zhang, M. J., Hu, Z. H., Akpek, G., . . . Cairo, M. S. (2014). Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. Biology of Blood and Marrow Transplantation, 20(7), 951-959. doi:10.1016/j.bbmt.2014.03.014

First Prev 1 2 3 4 5 Next Last